We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Customized Genomic Studies Reveal How Genes Influence Health

By LabMedica International staff writers
Posted on 02 Oct 2009
Print article
Two recent studies have used individual genetic data to reveal the powers and limits of the current understanding of how the genome influences human health and what genes can reveal about the ancestry of the people in the U.S. state of New Hampshire.

Published in the September 11, 2009, issue of the American Journal of Human Genetics, Dartmouth University (Hanover, NH, USA) professor Dr. Jason Moore and Vanderbilt University (Nashville, TN, USA) professor Dr. Scott Williams analyzed how personal genetic testing companies are using still-nascent genomic data to evaluate the health of their customers.

People can now buy inexpensive kits, submit a DNA sample (often a swab from the inside of a cheek or a little bit of saliva), and receive data about their susceptibility to a number of gene-influenced ailments, such as prostate cancer, Alzheimer's, or type II diabetes. Drs. Moore and Williams argue that people's knowledge of the human genome and its relationship to human health, while growing rapidly, is still in its infancy.

"The relationship between health and genetics is very complex," said Dr. Moore, professor of genetics and of community and family medicine at Dartmouth Medical School (DMS). "It's often a combination of multiple genes and multiple environmental factors that work together to increase or decrease your risk of disease. I don't think the knowledge base is sufficient to put genetics in the hands of the public quite yet."

The investigators admit that genetic research is progressing, and they cite the example of the discovery of the BRCA1 and BRCA2 genes and their role in breast cancer. However, the authors cautioned that, while there is no question these genes are involved in breast cancer, the underlying processes behind the genetic risk are still being worked out. "There is a perception that these tests can provide answers," stated Dr. Moore. "I used my own genetic material for this study, and my results didn't really tell me anything I didn't know, based on family history."

Drs. Moore and Williams call for refocusing and stepping up the research on gene-to-gene and gene-to-environment interactions. They explained that for quite a while, researchers have focused on single genes and clinical endpoints. The time has come, they noted, to accept rather than ignore the complexity of human traits as they are expressed by the whole genome working in concert. "Although genetic testing for common human diseases is not yet useful, using genetic testing results to reveal an individual's ancestry is increasingly reliable," remarked Dr. Moore. He and Ph.D. candidate Chantel Sloan recently extracted some genetic data for a study that examined the population structure of New Hampshire residents.

Published in the September 2009 issue of PLoS ONE (a journal of the Public Library of Science), this study by Drs. Sloan and Moore and their colleagues analyzed more than 1,000 genetic markers from 864 people in the state of New Hampshire. They discovered six subgroups of people with distinct genetic backgrounds including a group of Finnish and Russian/Polish/Lithuanian ancestry. "I knew that people would be primarily European," remarked Dr. Sloan. "What I didn't expect was the strong connection between genetic structure and people of Eastern European ancestry, which I learned is consistent with New Hampshire census and immigration data from 1870 to 1930."

Dr. Sloan utilized data initially compiled for a cancer study, therefore the genetic markers were cancer susceptibility genes rather than known ancestral genes, and the population being analyzed was not racially or geographically distinct. The study's findings challenge the assumption that large numbers of special genetic markers are needed to discover genetically distinct groups of people.

"This is an example of how personal genetic data can be used to help inform people of their ancestry," concluded Dr. Moore. "Informing people of their future health is still out of reach, though."

Related Links:
Dartmouth University
Vanderbilt University

New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
C-Reactive Protein Test
mLabs CRP
New
Thyroid Stimulating Hormone Assay
Neonatal TSH ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate Arc System has been granted US FDA 510(k) clearance (Photo courtesy of Accelerate Diagnostics)

Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR

Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.